The first NovoCure Ltd trade was made in Q2 2017.
Since then Joel Greenblatt bought shares six more times and sold shares on eight occasions. The investor sold all their shares in Q4 2021 and doesn't own any shares in NovoCure Ltd anymore.
Avg closing price
Price range
Sold -4.57 Thousand shares
Q4 2021
Avg closing price
$100.38
Price range
$75.08
-
$121.99
New holding (+4.57 Thousand shares)
Q3 2021
Avg closing price
$151.19
Price range
$116.17
-
$194.55
Sold -1.66 Thousand shares
Q2 2021
Avg closing price
$194.53
Price range
$130.40
-
$225.58
New holding (+1.66 Thousand shares)
Q1 2021
Avg closing price
$158.19
Price range
$124.11
-
$190.17
Sold -28.7 Thousand shares
Q2 2020
Avg closing price
$65.77
Price range
$57.20
-
$74.41
Sold 66.7% shares (-57.5 Thousand shares)
Q1 2020
Avg closing price
$79.03
Price range
$57.05
-
$95.75
Sold 5.0% shares (-4.54 Thousand shares)
Q4 2019
Avg closing price
$80.71
Price range
$68.30
-
$93.80
Increased shares by 61.0% (+34.4 Thousand shares)
Q3 2019
Avg closing price
$79.97
Price range
$61.86
-
$97.80
Increased shares by 688.4% (+49.3 Thousand shares)
Q2 2019
Avg closing price
$50.67
Price range
$42.22
-
$63.23
New holding (+7.16 Thousand shares)
Q1 2019
Avg closing price
$48.13
Price range
$31.96
-
$56.12
Sold -30.9 Thousand shares
Q2 2018
Avg closing price
$27.82
Price range
$19.85
-
$32.00
Sold 7.5% shares (-2.52 Thousand shares)
Q1 2018
Avg closing price
$21.51
Price range
$19.30
-
$23.65
Sold 9.1% shares (-3.36 Thousand shares)
Q4 2017
Avg closing price
$19.26
Price range
$16.30
-
$21.90
Increased shares by 19.2% (+5.92 Thousand shares)
Q3 2017